<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title38.html">
                                    Title 38
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/38CFR4.html">Part 4
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  4.104  Schedule of ratings--cardiovascular system.
                            </h3>
                            <p class="depth0">Diseases of the Heart------------------------------------------------------------------------</p><p class="depth0">Rating------------------------------------------------------------------------Note (1): Evaluate cor pulmonale, which is a form of secondary</p><p class="depth0">heart disease, as part of the pulmonary condition that causes</p><p class="depth0">it.Note (2): One MET (metabolic equivalent) is the energy cost of</p><p class="depth0">standing quietly at rest and represents an oxygen uptake of 3.5</p><p class="depth0">milliliters per kilogram of body weight per minute. When the</p><p class="depth0">level of METs at which dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope develops is required for evaluation, and a laboratory</p><p class="depth0">determination of METs by exercise testing cannot be done for</p><p class="depth0">medical reasons, an estimation by a medical examiner of the</p><p class="depth0">level of activity (expressed in METs and supported by specific</p><p class="depth0">examples, such as slow stair climbing or shoveling snow) that</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope may</p><p class="depth0">be used.7000 Valvular heart disease (including rheumatic heart disease):</p><p class="depth0">During active infection with valvular heart damage and for       100</p><p class="depth0">three months following cessation of therapy for the active</p><p class="depth0">infection..................................................</p><p class="depth0">Thereafter, with valvular heart disease (documented by</p><p class="depth0">findings on physical examination and either echocardiogram,</p><p class="depth0">Doppler echocardiogram, or cardiac catheterization)</p><p class="depth0">resulting in:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electro-cardiogram, echocardiogram, or X-ray...............</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7001 Endocarditis:</p><p class="depth0">For three months following cessation of therapy for active       100</p><p class="depth0">infection with cardiac involvement.........................</p><p class="depth0">Thereafter, with endocarditis (documented by findings on</p><p class="depth0">physical examination and either echocardiogram, Doppler</p><p class="depth0">echocardiogram, or cardiac catheterization) resulting in:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7002 Pericarditis:</p><p class="depth0">For three months following cessation of therapy for active       100</p><p class="depth0">infection with cardiac involvement.........................</p><p class="depth0">Thereafter, with documented pericarditis resulting in:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electro-cardiogram, echocardiogram, or X-ray...............</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7003 Pericardial adhesions:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electro-cardiogram, echocardiogram, or X-ray...............</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7004 Syphilitic heart disease:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................</p><p class="depth0">Note: Evaluate syphilitic aortic aneurysms under DC 7110 (aortic</p><p class="depth0">aneurysm).</p><p class="depth0">7005 Arteriosclerotic heart disease (Coronary artery disease):</p><p class="depth0">With documented coronary artery disease resulting in:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................</p><p class="depth0">Note: If nonservice-connected arteriosclerotic heart disease is</p><p class="depth0">superimposed on service-connected valvular or other non-</p><p class="depth0">arteriosclerotic heart disease, request a medical opinion as to</p><p class="depth0">which condition is causing the current signs and symptoms.</p><p class="depth0">7006 Myocardial infarction:</p><p class="depth0">During and for three months following myocardial infarction,     100</p><p class="depth0">documented by laboratory tests.............................</p><p class="depth0">Thereafter:</p><p class="depth0">With history of documented myocardial infarction, resulting</p><p class="depth0">in:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7007 Hypertensive heart disease:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7008 Hyperthyroid heart disease:</p><p class="depth0">Include as part of the overall evaluation for</p><p class="depth0">hyperthyroidism under DC 7900. However, when atrial</p><p class="depth0">fibrillation is present, hyperthyroidism may be evaluated</p><p class="depth0">either under DC 7900 or under DC 7010 (supraventricular</p><p class="depth0">arrhythmia), whichever results in a higher evaluation.7010 Supraventricular arrhythmias:</p><p class="depth0">Paroxysmal atrial fibrillation or other supraventricular          30</p><p class="depth0">tachycardia, with more than four episodes per year</p><p class="depth0">documented by ECG or Holter monitor........................</p><p class="depth0">Permanent atrial fibrillation (lone atrial fibrillation),         10</p><p class="depth0">or; one to four episodes per year of paroxysmal atrial</p><p class="depth0">fibrillation or other supraventricular tachycardia</p><p class="depth0">documented by ECG or Holter monitor........................7011 Ventricular arrhythmias (sustained):</p><p class="depth0">For indefinite period from date of hospital admission for        100</p><p class="depth0">initial evaluation and medical therapy for a sustained</p><p class="depth0">ventricular arrhythmia, or; for indefinite period from date</p><p class="depth0">of hospital admission for ventricular aneurysmectomy, or;</p><p class="depth0">with an automatic implantable Cardioverter-Defibrillator</p><p class="depth0"><em>(AICD)</em> in place............................................</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................</p><p class="depth0">Note: A rating of 100 percent shall be assigned from the date of</p><p class="depth0">hospital admission for initial evaluation and medical therapy</p><p class="depth0">for a sustained ventricular arrhythmia or for ventricular</p><p class="depth0">aneurysmectomy. Six months following discharge, the appropriate</p><p class="depth0">disability rating shall be determined by mandatory VA</p><p class="depth0">examination. Any change in evaluation based upon that or any</p><p class="depth0">subsequent examination shall be subject to the provisions of</p><p class="depth0">Sec.   3.105(e) of this chapter.</p><p class="depth0">7015 Atrioventricular block:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication or a pacemaker required..........</p><p class="depth0">Note: Unusual cases of arrhythmia such as atrioventricular block</p><p class="depth0">associated with a supraventricular arrhythmia or pathological</p><p class="depth0">bradycardia should be submitted to the Director, Compensation</p><p class="depth0">Service. Simple delayed P-R conduction time, in the absence of</p><p class="depth0">other evidence of cardiac disease, is not a disability.</p><p class="depth0">7016 Heart valve replacement (prosthesis):</p><p class="depth0">For indefinite period following date of hospital admission       100</p><p class="depth0">for valve replacement......................................</p><p class="depth0">Thereafter:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................</p><p class="depth0">Note: A rating of 100 percent shall be assigned as of the date</p><p class="depth0">of hospital admission for valve replacement. Six months</p><p class="depth0">following discharge, the appropriate disability rating shall be</p><p class="depth0">determined by mandatory VA examination. Any change in</p><p class="depth0">evaluation based upon that or any subsequent examination shall</p><p class="depth0">be subject to the provisions of Sec.   3.105(e) of this</p><p class="depth0">chapter.</p><p class="depth0">7017 Coronary bypass surgery:</p><p class="depth0">For three months following hospital admission for surgery...     100</p><p class="depth0">Thereafter:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload greater than 7 METs but not greater than 10 METs         10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................7018 Implantable cardiac pacemakers:</p><p class="depth0">For two months following hospital admission for implantation     100</p><p class="depth0">or reimplantation..........................................</p><p class="depth0">Thereafter:</p><p class="depth0">Evaluate as supraventricular arrhythmias (DC 7010),               10</p><p class="depth0">ventricular arrhythmias (DC 7011), or atrioventricular</p><p class="depth0">block (DC 7015). Minimum...................................</p><p class="depth0">Note: Evaluate implantable Cardioverter-Defibrillators (AICD's)</p><p class="depth0">under DC 7011.</p><p class="depth0">7019 Cardiac transplantation:</p><p class="depth0">For an indefinite period from date of hospital admission for     100</p><p class="depth0">cardiac transplantation....................................</p><p class="depth0">Thereafter:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Minimum.................................................      30</p><p class="depth0">Note: A rating of 100 percent shall be assigned as of the date</p><p class="depth0">of hospital admission for cardiac transplantation. One year</p><p class="depth0">following discharge, the appropriate disability rating shall be</p><p class="depth0">determined by mandatory VA examination. Any change in</p><p class="depth0">evaluation based upon that or any subsequent examination shall</p><p class="depth0">be subject to the provisions of Sec.   3.105(e) of this</p><p class="depth0">chapter.</p><p class="depth0">7020 Cardiomyopathy:</p><p class="depth0">Chronic congestive heart failure, or; workload of 3 METs or      100</p><p class="depth0">less results in dyspnea, fatigue, angina, dizziness, or</p><p class="depth0">syncope, or; left ventricular dysfunction with an ejection</p><p class="depth0">fraction of less than 30 percent...........................</p><p class="depth0">More than one episode of acute congestive heart failure in        60</p><p class="depth0">the past year, or; workload of greater than 3 METs but not</p><p class="depth0">greater than 5 METs results in dyspnea, fatigue, angina,</p><p class="depth0">dizziness, or syncope, or; left ventricular dysfunction</p><p class="depth0">with an ejection fraction of 30 to 50 percent..............</p><p class="depth0">Workload of greater than 5 METs but not greater than 7 METs       30</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; evidence of cardiac hypertrophy or dilatation on</p><p class="depth0">electrocardiogram, echocardiogram, or X-ray................</p><p class="depth0">Workload of greater than 7 METs but not greater than 10 METs      10</p><p class="depth0">results in dyspnea, fatigue, angina, dizziness, or syncope,</p><p class="depth0">or; continuous medication required.........................Diseases of the Arteries and Veins7101 Hypertensive vascular disease (hypertension and isolated</p><p class="depth0">systolic hypertension):</p><p class="depth0">Diastolic pressure predominantly 130 or more................      60</p><p class="depth0">Diastolic pressure predominantly 120 or more................      40</p><p class="depth0">Diastolic pressure predominantly 110 or more, or; systolic        20</p><p class="depth0">pressure predominantly 200 or more.........................</p><p class="depth0">Diastolic pressure predominantly 100 or more, or; systolic        10</p><p class="depth0">pressure predominantly 160 or more, or; minimum evaluation</p><p class="depth0">for an individual with a history of diastolic pressure</p><p class="depth0">predominantly 100 or more who requires continuous</p><p class="depth0">medication for control.....................................</p><p class="depth0">Note (1): Hypertension or isolated systolic hypertension must be</p><p class="depth0">confirmed by readings taken two or more times on at least three</p><p class="depth0">different days. For purposes of this section, the term</p><p class="depth0">hypertension means that the diastolic blood pressure is</p><p class="depth0">predominantly 90mm. or greater, and isolated systolic</p><p class="depth0">hypertension means that the systolic blood pressure is</p><p class="depth0">predominantly 160mm. or greater with a diastolic blood pressure</p><p class="depth0">of less than 90mm.Note (2): Evaluate hypertension due to aortic insufficiency or</p><p class="depth0">hyperthyroidism, which is usually the isolated systolic type,</p><p class="depth0">as part of the condition causing it rather than by a separate</p><p class="depth0">evaluation.Note (3): Evaluate hypertension separately from hypertensive</p><p class="depth0">heart disease and other types of heart disease.</p><p class="depth0">7110 Aortic aneurysm:</p><p class="depth0">If five centimeters or larger in diameter, or; if                100</p><p class="depth0">symptomatic, or; for indefinite period from date of</p><p class="depth0">hospital admission for surgical correction (including any</p><p class="depth0">type of graft insertion)...................................</p><p class="depth0">Precluding exertion.........................................      60</p><p class="depth0">Evaluate residuals of surgical correction according to organ</p><p class="depth0">systems affected.</p><p class="depth0">Note: A rating of 100 percent shall be assigned as of the date</p><p class="depth0">of admission for surgical correction. Six months following</p><p class="depth0">discharge, the appropriate disability rating shall be</p><p class="depth0">determined by mandatory VA examination. Any change in</p><p class="depth0">evaluation based upon that or any subsequent examination shall</p><p class="depth0">be subject to the provisions of Sec.   3.105(e) of this</p><p class="depth0">chapter.</p><p class="depth0">7111 Aneurysm, any large artery:</p><p class="depth0">If symptomatic, or; for indefinite period from date of           100</p><p class="depth0">hospital admission for surgical correction.................</p><p class="depth0">Following surgery:</p><p class="depth0">Ischemic limb pain at rest, and; either deep ischemic ulcers     100</p><p class="depth0">or ankle/brachial index of 0.4 or less.....................</p><p class="depth0">Claudication on walking less than 25 yards on a level grade       60</p><p class="depth0">at 2 miles per hour, and; persistent coldness of the</p><p class="depth0">extremity, one or more deep ischemic ulcers, or ankle/</p><p class="depth0">brachial index of 0.5 or less..............................</p><p class="depth0">Claudication on walking between 25 and 100 yards on a level       40</p><p class="depth0">grade at 2 miles per hour, and; trophic changes (thin skin,</p><p class="depth0">absence of hair, dystrophic nails) or ankle/brachial index</p><p class="depth0">of 0.7 or less.............................................</p><p class="depth0">Claudication on walking more than 100 yards, and; diminished      20</p><p class="depth0">peripheral pulses or ankle/brachial index of 0.9 or less...Note (1): The ankle/brachial index is the ratio of the systolic</p><p class="depth0">blood pressure at the ankle (determined by Doppler study)</p><p class="depth0">divided by the simultaneous brachial artery systolic blood</p><p class="depth0">pressure. The normal index is 1.0 or greater.Note (2): These evaluations are for involvement of a single</p><p class="depth0">extremity. If more than one extremity is affected, evaluate</p><p class="depth0">each extremity separately and combine (under Sec.   4.25),</p><p class="depth0">using the bilateral factor, if applicable.Note (3): A rating of 100 percent shall be assigned as of the</p><p class="depth0">date of hospital admission for surgical correction. Six months</p><p class="depth0">following discharge, the appropriate disability rating shall be</p><p class="depth0">determined by mandatory VA examination. Any change in</p><p class="depth0">evaluation based upon that or any subsequent examination shall</p><p class="depth0">be subject to the provisions of Sec.   3.105(e) of this</p><p class="depth0">chapter.</p><p class="depth0">7112 Aneurysm, any small artery:</p><p class="depth0">Asymptomatic................................................       0</p><p class="depth0">Note: If symptomatic, evaluate according to body system</p><p class="depth0">affected. Following surgery, evaluate residuals under the body</p><p class="depth0">system affected.</p><p class="depth0">7113 Arteriovenous fistula, traumatic:</p><p class="depth0">With high output heart failure..............................     100</p><p class="depth0">Without heart failure but with enlarged heart, wide pulse         60</p><p class="depth0">pressure, and tachycardia..................................</p><p class="depth0">Without cardiac involvement but with edema, stasis</p><p class="depth0">dermatitis, and either ulceration or cellulitis:</p><p class="depth0">Lower extremity.........................................      50</p><p class="depth0">Upper extremity.........................................      40</p><p class="depth0">With edema or stasis dermatitis:</p><p class="depth0">Lower extremity.........................................      30</p><p class="depth0">Upper extremity.........................................      207114 Arteriosclerosis obliterans:</p><p class="depth0">Ischemic limb pain at rest, and; either deep ischemic ulcers     100</p><p class="depth0">or ankle/brachial index of 0.4 or less.....................</p><p class="depth0">Claudication on walking less than 25 yards on a level grade       60</p><p class="depth0">at 2 miles per hour, and; either persistent coldness of the</p><p class="depth0">extremity or ankle/brachial index of 0.5 or less...........</p><p class="depth0">Claudication on walking between 25 and 100 yards on a level       40</p><p class="depth0">grade at 2 miles per hour, and; trophic changes (thin skin,</p><p class="depth0">absence of hair, dystrophic nails) or ankle/brachial index</p><p class="depth0">of 0.7 or less.............................................</p><p class="depth0">Claudication on walking more than 100 yards, and; diminished      20</p><p class="depth0">peripheral pulses or ankle/brachial index of 0.9 or less...</p><p class="depth0">Note (1): The ankle/brachial index is the ratio of the systolic</p><p class="depth0">blood pressure at the ankle (determined by Doppler study)</p><p class="depth0">divided by the simultaneous brachial artery systolic blood</p><p class="depth0">pressure. The normal index is 1.0 or greater.Note (2): Evaluate residuals of aortic and large arterial bypass</p><p class="depth0">surgery or arterial graft as arteriosclerosis obliterans.Note (3): These evaluations are for involvement of a single</p><p class="depth0">extremity. If more than one extremity is affected, evaluate</p><p class="depth0">each extremity separately and combine (under Sec.   4.25),</p><p class="depth0">using the bilateral factor (Sec.   4.26), if applicable.</p><p class="depth0">7115 Thrombo-angiitis obliterans (Buerger's Disease):</p><p class="depth0">Ischemic limb pain at rest, and; either deep ischemic ulcers     100</p><p class="depth0">or ankle/brachial index of 0.4 or less.....................</p><p class="depth0">Claudication on walking less than 25 yards on a level grade       60</p><p class="depth0">at 2 miles per hour, and; either persistent coldness of the</p><p class="depth0">extremity or ankle/brachial index of 0.5 or less...........</p><p class="depth0">Claudication on walking between 25 and 100 yards on a level       40</p><p class="depth0">grade at 2 miles per hour, and; trophic changes (thin skin,</p><p class="depth0">absence of hair, dystrophic nails) or ankle/brachial index</p><p class="depth0">of 0.7 or less.............................................</p><p class="depth0">Claudication on walking more than 100 yards, and; diminished      20</p><p class="depth0">peripheral pulses or ankle/brachial index of 0.9 or less...</p><p class="depth0">Note (1): The ankle/brachial index is the ratio of the systolic</p><p class="depth0">blood pressure at the ankle (determined by Doppler study)</p><p class="depth0">divided by the simultaneous brachial artery systolic blood</p><p class="depth0">pressure. The normal index is 1.0 or greater.Note (2): These evaluations are for involvement of a single</p><p class="depth0">extremity. If more than one extremity is affected, evaluate</p><p class="depth0">each extremity separately and combine (under Sec.   4.25),</p><p class="depth0">using the bilateral factor (Sec.   4.26), if applicable.</p><p class="depth0">7117 Raynaud's syndrome:</p><p class="depth0">With two or more digital ulcers plus autoamputation of one       100</p><p class="depth0">or more digits and history of characteristic attacks.......</p><p class="depth0">With two or more digital ulcers and history of                    60</p><p class="depth0">characteristic attacks.....................................</p><p class="depth0">Characteristic attacks occurring at least daily.............      40</p><p class="depth0">Characteristic attacks occurring four to six times a week...      20</p><p class="depth0">Characteristic attacks occurring one to three times a week..      10Note: For purposes of this section, characteristic attacks</p><p class="depth0">consist of sequential color changes of the digits of one or</p><p class="depth0">more extremities lasting minutes to hours, sometimes with pain</p><p class="depth0">and paresthesias, and precipitated by exposure to cold or by</p><p class="depth0">emotional upsets. These evaluations are for the disease as a</p><p class="depth0">whole, regardless of the number of extremities involved or</p><p class="depth0">whether the nose and ears are involved.</p><p class="depth0">7118 Angioneurotic edema:</p><p class="depth0">Attacks without laryngeal involvement lasting one to seven        40</p><p class="depth0">days or longer and occurring more than eight times a year,</p><p class="depth0">or; attacks with laryngeal involvement of any duration</p><p class="depth0">occurring more than twice a year...........................</p><p class="depth0">Attacks without laryngeal involvement lasting one to seven        20</p><p class="depth0">days and occurring five to eight times a year, or; attacks</p><p class="depth0">with laryngeal involvement of any duration occurring once</p><p class="depth0">or twice a year............................................</p><p class="depth0">Attacks without laryngeal involvement lasting one to seven        10</p><p class="depth0">days and occurring two to four times a year................7119 Erythromelalgia:</p><p class="depth0">Characteristic attacks that occur more than once a day, last     100</p><p class="depth0">an average of more than two hours each, respond poorly to</p><p class="depth0">treatment, and that restrict most routine daily activities.</p><p class="depth0">Characteristic attacks that occur more than once a day, last      60</p><p class="depth0">an average of more than two hours each, and respond poorly</p><p class="depth0">to treatment, but that do not restrict most routine daily</p><p class="depth0">activities.................................................</p><p class="depth0">Characteristic attacks that occur daily or more often but         30</p><p class="depth0">that respond to treatment..................................</p><p class="depth0">Characteristic attacks that occur less than daily but at          10</p><p class="depth0">least three times a week and that respond to treatment.....</p><p class="depth0">Note: For purposes of this section, a characteristic attack of</p><p class="depth0">erythromelalgia consists of burning pain in the hands, feet, or</p><p class="depth0">both, usually bilateral and symmetrical, with increased skin</p><p class="depth0">temperature and redness, occurring at warm ambient</p><p class="depth0">temperatures. These evaluations are for the disease as a whole,</p><p class="depth0">regardless of the number of extremities involved.</p><p class="depth0">7120 Varicose veins:</p><p class="depth0">With the following findings attributed to the effects of         100</p><p class="depth0">varicose veins: Massive board-like edema with constant pain</p><p class="depth0">at rest....................................................</p><p class="depth0">Persistent edema or subcutaneous induration, stasis               60</p><p class="depth0">pigmentation or eczema, and persistent ulceration..........</p><p class="depth0">Persistent edema and stasis pigmentation or eczema, with or       40</p><p class="depth0">without intermittent ulceration............................</p><p class="depth0">Persistent edema, incompletely relieved by elevation of           20</p><p class="depth0">extremity, with or without beginning stasis pigmentation or</p><p class="depth0">eczema.....................................................</p><p class="depth0">Intermittent edema of extremity or aching and fatigue in leg      10</p><p class="depth0">after prolonged standing or walking, with symptoms relieved</p><p class="depth0">by elevation of extremity or compression hosiery...........</p><p class="depth0">Asymptomatic palpable or visible varicose veins.............       0</p><p class="depth0">Note: These evaluations are for involvement of a single</p><p class="depth0">extremity. If more than one extremity is involved, evaluate</p><p class="depth0">each extremity separately and combine (under Sec.   4.25),</p><p class="depth0">using the bilateral factor (Sec.   4.26), if applicable.</p><p class="depth0">7121 Post-phlebitic syndrome of any etiology:</p><p class="depth0">With the following findings attributed to venous disease:</p><p class="depth0">Massive board-like edema with constant pain at rest.....     100</p><p class="depth0">Persistent edema or subcutaneous induration, stasis           60</p><p class="depth0">pigmentation or eczema, and persistent ulceration......</p><p class="depth0">Persistent edema and stasis pigmentation or eczema, with      40</p><p class="depth0">or without intermittent ulceration.....................</p><p class="depth0">Persistent edema, incompletely relieved by elevation of       20</p><p class="depth0">extremity, with or without beginning stasis</p><p class="depth0">pigmentation or eczema.................................</p><p class="depth0">Intermittent edema of extremity or aching and fatigue in      10</p><p class="depth0">leg after prolonged standing or walking, with symptoms</p><p class="depth0">relieved by elevation of extremity or compression</p><p class="depth0">hosiery................................................</p><p class="depth0">Asymptomatic palpable or visible varicose veins.........       0</p><p class="depth0">Note: These evaluations are for involvement of a single</p><p class="depth0">extremity. If more than one extremity is involved, evaluate</p><p class="depth0">each extremity separately and combine (under Sec.   4.25),</p><p class="depth0">using the bilateral factor (Sec.   4.26), if applicable.</p><p class="depth0">7122 Cold injury residuals:</p><p class="depth0">With the following in affected parts:</p><p class="depth0">Arthralgia or other pain, numbness, or cold sensitivity       30</p><p class="depth0">plus two or more of the following: tissue loss, nail</p><p class="depth0">abnormalities, color changes, locally impaired</p><p class="depth0">sensation, hyperhidrosis, X-ray abnormalities</p><p class="depth0">(osteoporosis, subarticular punched out lesions, or</p><p class="depth0">osteoarthritis)........................................</p><p class="depth0">Arthralgia or other pain, numbness, or cold sensitivity       20</p><p class="depth0">plus tissue loss, nail abnormalities, color changes,</p><p class="depth0">locally impaired sensation, hyperhidrosis, or X-ray</p><p class="depth0">abnormalities (osteoporosis, subarticular punched out</p><p class="depth0">lesions, or osteoarthritis)............................</p><p class="depth0">Arthralgia or other pain, numbness, or cold sensitivity.      10</p><p class="depth0">Note (1): Separately evaluate amputations of fingers or toes,</p><p class="depth0">and complications such as squamous cell carcinoma at the site</p><p class="depth0">of a cold injury scar or peripheral neuropathy, under other</p><p class="depth0">diagnostic codes. Separately evaluate other disabilities that</p><p class="depth0">have been diagnosed as the residual effects of cold injury,</p><p class="depth0">such as Raynaud's phenomenon, muscle atrophy, etc., unless they</p><p class="depth0">are used to support an evaluation under diagnostic code 7122.Note (2): Evaluate each affected part (e.g., hand, foot, ear,</p><p class="depth0">nose) separately and combine the ratings in accordance with</p><p class="depth0">Sec.  Sec.   4.25 and 4.26.</p><p class="depth0">7123 Soft tissue sarcoma (of vascular origin)...................     100</p><p class="depth0">Note: A rating of 100 percent shall continue beyond the</p><p class="depth0">cessation of any surgical, X-ray, antineoplastic chemotherapy</p><p class="depth0">or other therapeutic procedure. Six months after discontinuance</p><p class="depth0">of such treatment, the appropriate disability rating shall be</p><p class="depth0">determined by mandatory VA examination. Any change in</p><p class="depth0">evaluation based upon that or any subsequent examination shall</p><p class="depth0">be subject to the provisions of Sec.   3.105(e) of this</p><p class="depth0">chapter. If there has been no local recurrence or metastasis,</p><p class="depth0">rate on residuals.------------------------------------------------------------------------

(Authority: 38 U.S.C. 1155)
[62 FR 65219, Dec. 11, 1997, as amended at 63 FR 37779, July 14, 1998; 71 FR52460, Sept. 6, 2006; 79 FR 2100, Jan. 13, 2014]</p><p class="depth0">The Digestive System</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ❤.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
